Ledger.Open graph →
SEC Form D · Amendment · filed November 8, 2018

RHEOS MEDICINES, INC

Offering
Sold
$27.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Stephen Sherwin · CAMBRIDGE, MADirectorJeffrey Bluestone · CAMBRIDGE, MADirectorAbbie Celniker · CAMBRIDGE, MADirectorCary Pfeffer · CAMBRIDGE, MADirectorJ. Duncan Higgons · CAMBRIDGE, MADirectorDan Matloff · CAMBRIDGE, MAExecRyan Cohlhepp · CAMBRIDGE, MAExecSanjay Keswani · CAMBRIDGE, MAExec · DirectorGad Soffer · CAMBRIDGE, MAExecCeleste Burgoyne · COSTA MESA, CADirectorChristopher Kirkland · South Jordan, UTDirectorArne R. Halenza · Cambridge, MADirectorErik Anderson · COSTA MESA, CADirectorDavid Blumberg · Vancouver, British Columbia, CanadaExecZachary K. Ellis · Pittsburgh, PAExecStephen Ufford · Vancouver, British Columbia, CanadaDirectorShaun Sharabi · Los Angeles, CAExec · DirectorWilliam C. Harrington · Baya Cynwyd, PADirectorCasey C. Tansey · Menlo Park, CADirectorAnthony C. Natale · New York, NYDirectorLoren Straub · Peachtree Corners, GADirectorJon Haley · Peachtree Corners, GAExecJohn Armstrong · Peachtree Corners, GAExecDavid T. Jones · MANCHACA, TXDirectorMorris Denton · MANCHACA, TXExec · DirectorGad Soffer · CAMBRIDGE, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗